Cargando…

Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries

BACKGROUND: In the pandemic time, many low- and middle-income countries are experiencing restricted access to COVID-19 vaccines. Access to imported vaccines or ways to produce them locally became the principal source of hope for these countries. But developing a strategy for success in obtaining and...

Descripción completa

Detalles Bibliográficos
Autores principales: Aripov, Timur, Wikler, Daniel, Asadov, Damin, Tulekov, Zhangir, Murzabekova, Totugul, Munir, Kerim M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906360/
https://www.ncbi.nlm.nih.gov/pubmed/35264173
http://dx.doi.org/10.1186/s12910-022-00764-1
_version_ 1784665391884140544
author Aripov, Timur
Wikler, Daniel
Asadov, Damin
Tulekov, Zhangir
Murzabekova, Totugul
Munir, Kerim M.
author_facet Aripov, Timur
Wikler, Daniel
Asadov, Damin
Tulekov, Zhangir
Murzabekova, Totugul
Munir, Kerim M.
author_sort Aripov, Timur
collection PubMed
description BACKGROUND: In the pandemic time, many low- and middle-income countries are experiencing restricted access to COVID-19 vaccines. Access to imported vaccines or ways to produce them locally became the principal source of hope for these countries. But developing a strategy for success in obtaining and allocating vaccines was not easy task. The governments in those countries have faced the difficult decision whether to accept or reject offers of vaccine diplomacy, weighing the price and availability of COVID-19 vaccines against the concerns over their efficacy and safety. We aimed to analyze public opinion regarding the governmental strategies to obtain COVID-19 vaccines in three Central Asian countries, focusing particularly on possible ethical issues. METHODS: We searched for opinions expressed either in Russian or in the respective national languages. We provided data on the debate within three countries, drawn from social media postings and other sources. The opinion data was not restricted by source and time. This allowed collecting a wide range of possible opinions that could be expressed regarding COVID-19 vaccine supply and human participation in the vaccine trial. We recognized ethical issues and possible questions concerning different ethical frameworks. We also considered scientific data and other information, in the process of reasoning. RESULTS: As a result, public views on their respective government policies on COVID-19 vaccine supply ranged from strongly negative to slightly positive. We extracted the most important issues from public debates, for our analysis. The first issue involved trade-offs between quantity, speed, price, freedom, efficacy, and safety in the vaccines. The second set of issues arose in connection with the request to site a randomized trial in one of the countries (Uzbekistan). After considering additional evidence, we weighed individual and public risks against the benefits to make specific judgements concerning every issue. CONCLUSIONS: We believe that our analysis would be a helpful example of solving ethical issues that can arise concerning COVID-19 vaccine supply around the world. The public view can be highly critical, helping to spot such issues. An ignoring this view can lead to major problems, which in turn, can become a serious obstacle for the vaccine coverage and epidemics’ control in the countries and regions.
format Online
Article
Text
id pubmed-8906360
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89063602022-03-10 Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries Aripov, Timur Wikler, Daniel Asadov, Damin Tulekov, Zhangir Murzabekova, Totugul Munir, Kerim M. BMC Med Ethics Research BACKGROUND: In the pandemic time, many low- and middle-income countries are experiencing restricted access to COVID-19 vaccines. Access to imported vaccines or ways to produce them locally became the principal source of hope for these countries. But developing a strategy for success in obtaining and allocating vaccines was not easy task. The governments in those countries have faced the difficult decision whether to accept or reject offers of vaccine diplomacy, weighing the price and availability of COVID-19 vaccines against the concerns over their efficacy and safety. We aimed to analyze public opinion regarding the governmental strategies to obtain COVID-19 vaccines in three Central Asian countries, focusing particularly on possible ethical issues. METHODS: We searched for opinions expressed either in Russian or in the respective national languages. We provided data on the debate within three countries, drawn from social media postings and other sources. The opinion data was not restricted by source and time. This allowed collecting a wide range of possible opinions that could be expressed regarding COVID-19 vaccine supply and human participation in the vaccine trial. We recognized ethical issues and possible questions concerning different ethical frameworks. We also considered scientific data and other information, in the process of reasoning. RESULTS: As a result, public views on their respective government policies on COVID-19 vaccine supply ranged from strongly negative to slightly positive. We extracted the most important issues from public debates, for our analysis. The first issue involved trade-offs between quantity, speed, price, freedom, efficacy, and safety in the vaccines. The second set of issues arose in connection with the request to site a randomized trial in one of the countries (Uzbekistan). After considering additional evidence, we weighed individual and public risks against the benefits to make specific judgements concerning every issue. CONCLUSIONS: We believe that our analysis would be a helpful example of solving ethical issues that can arise concerning COVID-19 vaccine supply around the world. The public view can be highly critical, helping to spot such issues. An ignoring this view can lead to major problems, which in turn, can become a serious obstacle for the vaccine coverage and epidemics’ control in the countries and regions. BioMed Central 2022-03-09 /pmc/articles/PMC8906360/ /pubmed/35264173 http://dx.doi.org/10.1186/s12910-022-00764-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Aripov, Timur
Wikler, Daniel
Asadov, Damin
Tulekov, Zhangir
Murzabekova, Totugul
Munir, Kerim M.
Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries
title Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries
title_full Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries
title_fullStr Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries
title_full_unstemmed Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries
title_short Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries
title_sort social network-based ethical analysis of covid-19 vaccine supply policy in three central asian countries
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906360/
https://www.ncbi.nlm.nih.gov/pubmed/35264173
http://dx.doi.org/10.1186/s12910-022-00764-1
work_keys_str_mv AT aripovtimur socialnetworkbasedethicalanalysisofcovid19vaccinesupplypolicyinthreecentralasiancountries
AT wiklerdaniel socialnetworkbasedethicalanalysisofcovid19vaccinesupplypolicyinthreecentralasiancountries
AT asadovdamin socialnetworkbasedethicalanalysisofcovid19vaccinesupplypolicyinthreecentralasiancountries
AT tulekovzhangir socialnetworkbasedethicalanalysisofcovid19vaccinesupplypolicyinthreecentralasiancountries
AT murzabekovatotugul socialnetworkbasedethicalanalysisofcovid19vaccinesupplypolicyinthreecentralasiancountries
AT munirkerimm socialnetworkbasedethicalanalysisofcovid19vaccinesupplypolicyinthreecentralasiancountries